Publications

5539 Results

O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.

Authors
SC Schold;D Kokkinakis;S Chang;M Berger;K Hess;D Schiff;HI Robins;M Mehta;KL Fink;RL Davis;M Prados
Journal / Conference
Neuro-Oncology Jan;6(1):28-32
Year
2004
Research Committee(s)
Brain
PMID
PMID14769137
PMC
PMC1871964

Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer

Authors
IC Henderson;DA Berry;GD Demetri;CT Cirrincione;L Goldstein;S Martino;JN Ingle;MR Cooper;DF Hayes;KH Tkaczuk;G Fleming;JF Holland;DB Duggan;JT Carpenter;E Frei, III;RL Schilsky;WC Wood;HB Muss;L Norton
Journal / Conference
Journal of Clinical Oncology 21(6):976-983
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

A phase II study of 13-cis retinoic acid plus interferon a-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893)

Authors
RT Skeel;J Huang;J Manola;G Wilding;R Dreicer;P Walker;F Muggia;ED Crawford;JP Dutcher;PJ Loehrer
Journal / Conference
Cancer Investigation 21(1):41-46
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9403 (E3893)

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes 20 year results of a Southwest Oncology Group study

Authors
SE Rivkin;S Green;D Lew;JJ Costanzi;JW Athens;CK Osborne;CB Vaughn;S Martino
Journal / Conference
Cancer 97(1):21-29
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: and Intergroup trial (E1193)

Authors
GW Sledge;D Neuberg;P Bernardo;JN Ingle;S Martino;EK Rowinsky;WC Wood
Journal / Conference
Journal of Clinical Oncology 21(4):588-592
Year
2003
Research Committee(s)
Breast

Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial

Authors
M Markman;T Glass;HO Smith;KD Hatch;GR Weiss;SA Taylor;JW Goodwin;DS Alberts
Journal / Conference
Gynecologic Oncology 88:282-288
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
S9618

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

Authors
DJ Adelstein;Y Li;GL Adams;H Wagner Jr;JA Kish;JF Ensley;DE Schuller;AA Forastiere
Journal / Conference
Journal of Clinical Oncology 21(1):92-98
Year
2003
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9059 (E-1392) (INT-0126)

Gene expression profile of serial samples of transformed B-cell lymphomas.

Authors
S de Vos;WK Hofmann;TM Grogan;U Krug;M Schrage;TP Miller;J Braun;W Wachsman;HP Koeffler;JH Said
Journal / Conference
Laboratory Investigation 83(2):271-285
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Adenoma recurrences after resection of colorectal carcinoma: Results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study

Authors
DZJ Chu;K Chansky;DS Alberts;FL Meyskens;CM Fenoglio-Preiser;SE Rivkin;GM Mills;JK Giguere;GE Goodman;JL Abbruzzese;SM Lippman
Journal / Conference
Annals of Surgical Oncology 10(8):870-875
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9041

High-dose ifosfamide with mesna and granuloctye-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma

Authors
SM Talbot;C Rankin;RN Taub;SP Balcerzak;N Bhoopalam;RA Chapman;LH Baker;EL Middleman;KH Antman
Journal / Conference
Cancer 98(2):331-336
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9341